D2team is a team of nonclinical experts offering ‘concept to commercialization’ consultation services for innovators and drug discoverers seeking to maximize the potential value of their innovative ideas into clinical stage assets.
The team has been assembled to bring together years of drug discovery and development experience in pharmacology, toxicology and all types of regulatory interaction and documentation.
D2team adopts a fully peer reviewed project management service structure to provide a 360º analysis of all aspects of drug development, offering clients the flexibility of an in-house project team.
This team is able to focus on all aspects of nonclinical drug development at all stages of the value chain. Our services are equally applicable to:
-
- academic, SMEs and start-up innovators seeking funding or IND submission
-
- investors
- biotechnology and pharma preclinical and clinical stage project teams
We have assembled experts that have worked together as a team in the past, and have experience in bringing pharmaceutical drug candidates to the market. We have combined our R&D expertise to launch D2team: Annelieke Peters PhD ERT; Peter Gilmour PhD; Anja Slikkerveer MD PhD ERT; Danny Burg PhD ERT; together with our trusted partner(s).